Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
StepStone Group
STEP
$3.61B
| $436K | ﹤0.01% |
17,306
-20,598
| -54% | -$576K |
|
1777
Commault Systems
CVLT
$4.88B
| $436K | ﹤0.01% |
6,930
| – | – |
|
1778
Axos Financial
AX
$5.77B
| $435K | ﹤0.01% |
11,402
+2,600
| +30% | +$99.1K |
|
1779
Nu Skin
NUS
$252M
| $435K | ﹤0.01% |
10,315
-10,315
| -50% | -$397K |
|
1780
Moog Inc Class A
MOG.A
$12.4B
| $435K | ﹤0.01% |
4,961
+1
| +0% | +$84 |
|
1781
Strategy Inc
MSTR
$34.1B
| $435K | ﹤0.01% |
30,660
+4,840
| +19% | +$98.9K |
|
|
MDRX
1782
DELISTED
Veradigm Inc. Common Stock
MDRX
| $434K | ﹤0.01% |
24,582
-24,584
| -50% | -$412K |
|
1783
Gentherm
THRM
$1.25B
| $433K | ﹤0.01% |
6,641
+1
| +0% | +$65 |
|
1784
Cracker Barrel
CBRL
$1.26B
| $431K | ﹤0.01% |
4,550
+1,073
| +31% | +$112K |
|
1785
First Financial Bancorp
FFBC
$3.55B
| $431K | ﹤0.01% |
17,784
-10,186
| -36% | -$250K |
|
1786
Peloton Interactive
PTON
$2.77B
| $431K | ﹤0.01% |
54,202
-54,206
| -50% | -$520K |
|
1787
Cathay General Bancorp
CATY
$4.22B
| $430K | ﹤0.01% |
10,555
-10,553
| -50% | -$457K |
|
|
DNB
1788
DELISTED
Dun & Bradstreet
DNB
| $429K | ﹤0.01% |
34,988
-34,996
| -50% | -$449K |
|
|
NVSA
1789
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
| $429K | ﹤0.01% |
42,519
-42,517
| -50% | -$425K |
|
1790
First Merchants
FRME
$2.68B
| $429K | ﹤0.01% |
10,436
-10,434
| -50% | -$441K |
|
1791
Renasant Corp
RNST
$3.98B
| $429K | ﹤0.01% |
11,401
-11,401
| -50% | -$431K |
|
1792
United Natural Foods
UNFI
$3.08B
| $426K | ﹤0.01% |
11,014
-11,014
| -50% | -$456K |
|
1793
Red Rock Resorts
RRR
$3.77B
| $424K | ﹤0.01% |
10,597
-10,597
| -50% | -$435K |
|
|
BIOT
1794
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $423K | ﹤0.01% |
41,862
-41,568
| -50% | -$416K |
|
1795
Mercury Systems
MRCY
$5.83B
| $422K | ﹤0.01% |
9,444
| – | – |
|
1796
WaFd
WAFD
$2.72B
| $422K | ﹤0.01% |
12,586
-8,384
| -40% | -$293K |
|
1797
Four Corners Property Trust
FCPT
$2.81B
| $422K | ﹤0.01% |
16,284
-9,286
| -36% | -$239K |
|
|
OSH
1798
DELISTED
Oak Street Health, Inc.
OSH
| $422K | ﹤0.01% |
19,620
-19,624
| -50% | -$410K |
|
1799
Energizer
ENR
$1.44B
| $421K | ﹤0.01% |
12,555
-12,555
| -50% | -$386K |
|
1800
Sterling Infrastructure
STRL
$18.3B
| $420K | ﹤0.01% |
12,819
-19,713
| -61% | -$580K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.